We are live on ! Find out more
HP

Harbourvest Partners Portfolio holdings

AUM $101M
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
+11.26%
1 Year Est. Return
-38.13%
3 Year Est. Return
-6.18%
5 Year Est. Return
-50.73%
10 Year Est. Return
+34.53%
AUM
$218M
AUM Growth
+$42.1M
Cap. Flow
+$23.9M
Cap. Flow %
10.93%
Top 10 Hldgs %
97.04%
Holding
27
New
8
Increased
–
Reduced
4
Closed
5

Top Buys

Rank Stock Value
1
HAPN
Happen Inc
HAPN
+$21.7M
2
SAGE
Sage Therapeutics
SAGE
+$3.93M
3
FMI
Foundation Medicine, Inc.
FMI
+$2.28M
4
INXN
Interxion Holding N.V.
INXN
+$2.14M
5
CLVS
Clovis Oncology, Inc.
CLVS
+$1.81M

Top Sells

Rank Stock Value
1
CRTO icon
Criteo
CRTO
+$3.06M
2
NMBL
Nimble Storage, Inc.
NMBL
+$2.84M
3
GOGO icon
Gogo Inc
GOGO
+$927K
4
LRMR icon
Larimar Therapeutics
LRMR
+$826K
5
MKTO
MARKETO INC COM STK (DE)
MKTO
+$765K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 76.18%
2 Financials 8.2%
3 Healthcare 5.3%
4 Communication Services 1.15%
5 Industrials 0.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
W icon
1
Wayfair
W
$12.5B
$166M 76.09%
4,413,282
– –
HAPN
2
Happen Inc
HAPN
$2.19B
$17.9M 8.2%
+242,867
New +$21.7M
ENVI
3
DELISTED
ENVIVIO INC COM STK (DE)
ENVI
$6.92M 3.17%
3,639,939
– –
FNJN
4
DELISTED
Finjan Holdings, Inc.
FNJN
$5.94M 2.72%
4,303,435
– –
SAGE
5
DELISTED
Sage Therapeutics
SAGE
$4.47M 2.05%
+61,180
New +$3.93M
LRMR icon
6
Larimar Therapeutics
LRMR
$398M
$2.68M 1.23%
6,453
-1,975
-23% -$826K
SCTY
7
DELISTED
SolarCity Corporation
SCTY
$2.08M 0.95%
38,870
– –
INXN
8
DELISTED
Interxion Holding N.V.
INXN
$1.99M 0.91%
+72,058
New +$2.14M
FMI
9
DELISTED
Foundation Medicine, Inc.
FMI
$1.91M 0.88%
+56,567
New +$2.28M
CLVS
10
DELISTED
Clovis Oncology, Inc.
CLVS
$1.85M 0.85%
+21,100
New +$1.81M
AWAY
11
DELISTED
HOMEAWAY INC COM
AWAY
$1.56M 0.72%
50,244
– –
ZU
12
DELISTED
ZULILY INC CLASS A COMMON STOCK
ZU
$1.11M 0.51%
85,355
– –
MKTO
13
DELISTED
MARKETO INC COM STK (DE)
MKTO
$808K 0.37%
28,798
-26,667
-48% -$765K
KITE
14
DELISTED
Kite Pharma, Inc.
KITE
$710K 0.33%
+11,640
New +$664K
ARDX icon
15
Ardelyx
ARDX
$1.25B
$520K 0.24%
32,584
-1,086
-3% -$13.7K
META icon
16
Meta Platforms (Facebook)
META
$1.51T
$514K 0.24%
+5,993
New +$489K
YDLE
17
DELISTED
YODLEE INC COMMON STOCK
YDLE
$446K 0.2%
+30,907
New +$427K
ECOM
18
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$341K 0.16%
28,512
– –
PBPB
19
DELISTED
Potbelly
PBPB
$194K 0.09%
15,802
-38,376
-71% -$539K
EPZM
20
DELISTED
Epizyme, Inc
EPZM
$125K 0.06%
5,196
– –
OPWR
21
DELISTED
OPOWER INC COM STK (DE)
OPWR
$91K 0.04%
7,939
– –
KBIO
22
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
$28K 0.01%
7,201
– –
CRTO icon
23
Criteo
CRTO
$1.06B
– –
-77,347
Closed -$3.06M
GOGO icon
24
Gogo Inc
GOGO
$550M
– –
-48,653
Closed -$927K
VCYT icon
25
Veracyte
VCYT
$4.44B
– –
-11,101
Closed -$81K
1
2

Similar funds

VCM
Vines Capital Management Monroe, Louisiana $101M AUM
TCI
Triveni Capital Investments Stamford, Connecticut $101M AUM
RPC
Royal Palms Capital Whitefish, Montana $101M AUM
XC
XY Capital Central, Hong Kong $101M AUM 1.14% 1-Year Est. Return
AWA
Ark Wealth Advisors Yorba Linda, California $101M AUM
HWM
Hobbs Wealth Management Zionsville, Indiana $101M AUM 22.3% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
ROP
Rule One Partners Moreland, Georgia $101M AUM 6.3% 1-Year Est. Return

Harbourvest Partners's Q2 2015 Portfolio in Review

As of Q2 2015, Harbourvest Partners held 27 positions worth $218M, up 24% from $176M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Harbourvest Partners deployed $23.9M of net new capital in Q2 2015, opening 8 new positions. Its largest new stake was Happen Inc: 242,867 shares worth $17.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 76% of assets, down from 81% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Larimar Therapeutics, an estimated $826K trimmed.

  • Harbourvest Partners's largest Q2 2015 buy was Happen Inc: 242,867 shares worth $17.9M.
  • Harbourvest Partners's biggest Q2 2015 reduction was Larimar Therapeutics, cutting an estimated $826K.
  • Harbourvest Partners fully exited Criteo in Q2 2015, selling an estimated $3.06M.
  • Harbourvest Partners's ten largest holdings make up 97% of its $218M portfolio in Q2 2015.
  • Harbourvest Partners opened 8 new positions and closed 5 in Q2 2015.
  • Harbourvest Partners's portfolio value rose 24% quarter-over-quarter to $218M.

Based on Harbourvest Partners's 13F filing for Q2 2015, filed 14 Aug 2015.